Cerebral ischemic tolerance mediated by toll like receptor signal transduction pathway

Chinese Pharmacological Bulletin

Volumn 22, Issue 1, 2006, Pages 9-13

  Li, Yong Wang ^a   Wang, Bao Guo ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemia; Signal transduction; Tolerance; Toll like receptor

Indexed keywords

ANESTHETIC AGENT; CYTOKINE; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR;

ARTICLE; BRAIN ISCHEMIA; CELL DAMAGE; HYPOXIA; INFLAMMATION; LIPID RAFT; MEMBRANE FLUIDITY; NEGATIVE FEEDBACK; SIGNAL TRANSDUCTION; TIME; TISSUE INJURY; UPREGULATION;

EID: 33646189833     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Zemke D, Smith JL, Reeves MJ, Majid A. Ischemia and ischemic tolerance in the brain: an overview[J]. Neurotoxicology, 2004, 25 (6): 895-904.
2. Kariko K, Weissman D, Welsh FA. Inhibition of toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance [J]. J Cereb Blood Flow Metab, 2004, 24(11):1288-304.
3. Fan H, Cook JA. Molecular mechanisms of endotoxin tolerance [J]. J Endotoxin Res, 2004, 10(1): 71-4
4. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response[J]. Nature, 2000, 406: 782-7.
5. Bastide M, Gele P, Petrault O et al. Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance[J]. J Cereb Blood Flow Metab, 2003, 23(2): 399-05.
6. Langdale LA, Kajikawa O, Krevert C et al. Sustained tolerance to lipopolysaccharide after liver isehemia-reperfusion injury[J]. Shock, 2003, 19(4): 553-8.
7. Yoshimura A, Mori H, Ohishi M et al. Negative regulation of cytokine-signaling influences inflammation[J]. Curr Opin Immunol, 2003, 15(6): 704-8.
8. Cui X, Rouhani FN, Hawari F et al. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding[J]. J Immunol, 2003, 171(12): 6814-9.
9. Mantovani A, Locati M, Polentarutti N et al. Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR[J]. J Leukoc Biol, 2004, 12(1):12.
10. Brint EK, Xu D, Liu H et al. ST2 is an inhibitor of interleukin 1 receptor and Toll like receptor 4 signaling and maintains endotoxin tolerance[J]. Nat Immunol, 2004, 5(2): 373-9.
11. Burns K, Janssens S, Brissoni B et al. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4[J]. J Exp Med, 2003, 197(2): 263-8.
12. Fukao T, Koyasu S. PI3K and negative regulation of TLR signaling[J]. Trends Immunol, 2003, 24(3): 358-63.
13. Lai WS, Kennington EA, Blackshear PJ. Tristetraprolin and its family members can promote the cell-free deadenylation of AUrich element-containing mRNAs by poly (A) ribonuclease[J]. Mol Cell Biol, 2003, 23(16): 3798-812.
14. Kinjyo I, Hanada T, Inagaki-Ohara K et al. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation[J]. Immunity, 2002, 17(4): 583-91.
15. Sosic D, Richardson JA, Yu K et al. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity[J]. Cell, 2003, 112(2): 169-80.
16. Wald D, Qin J, Zhao Z et al. SIGIRR, a negative regulator of Toll like receptor-interleukin 1 receptor signaling[J]. Nat Immunol, 2003, 4(7): 920-7.
17. Zhang G, Ghosh S. Negative regulation of Toll-like receptor mediated signaling by Tollip[J]. J Biol Chem, 2002, 277(8): 7059-65.
18. Laflamme N, Echchannaoui H, Landmann R et al. Cooperation between Toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria[J]. Eur J Immunol, 2003, 33(8): 1127-38.
19. Bsibsi M, Ravid R, Gveric D et al. Broad expression of Toll-like receptors in the human central nervous system[J]. J Neuropathol Exp Neurol, 2002, 61(7): 1013-21.
20. Asea A, Rehli M, Kabingu E et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4[J]. J Biol Chem. 2002, 277(15): 15028-34.
21. Johnson GB, Brunn GJ, Kodaira Y et al. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4[J]. J Immunol, 2002, 168(18): 5233-9.
22. Biragyn A, Ruffini PA, Leifer CA et al. Toli-like receptor 4-dependent activation of dendritic cells by beta-defensin 2[J]. Science, 2002, 298(8): 1025-9.
23. Devaney JM, Greene CM, Taggart CC et al. Neutrophil elastase up-regulates interleukin-8 via Toll-like receptor 4[J]. FEBS Lett, 2003, 544(1): 129-32.
24. Zeyda M, Staffler G, Horejsi V et al. LAT displacement from lipid rafts as a molecular mechanism for the inhibition of T cell signaling by polyunsaturated fatty acids[J]. J Biol Chem, 2002, 277(25): 28418-23.